BOPH Stock UPDATES Bohai Pharmaceutical (BOPH) 0.9000 10/22/2014
Post# of 273217
Bohai Pharmaceuticals Expects 2014 Revenue of $175 Million, Cites 'Broad Positive Developments' for Fiscal 2015
ACCESSWIRE - Mon Aug 18, 7:22AM CDT
YANTAI, China / ACCESSWIRE / August 18, 2014 / Bohai Pharmaceuticals Group, Inc. (OTCQB: BOPH), a leading manufacturer and marketer of traditional Chinese medicine (TCM), today said its revenue for fiscal 2014 ended June 30 is expected to total about $175 million, a 15 percent increase on the $151.8 million in revenue for fiscal 2013.
Bohai Pharmaceuticals Updates Corporate Website
ACCESSWIRE - Tue Jul 29, 7:19AM CDT
YANTAI, CHINA / ACCESSWIRE / July 28, 2014 / Bohai Pharmaceuticals Group, Inc. (OTCQB: BOPH), a leading manufacturer and marketer of traditional Chinese medicine (TCM), today said it has updated its company website to include new corporate and industry information.
Bohai Products Picked up by Nearly 4,000 New Chinese Medical Facilities in Six-Month Span
eTeligis - Thu Jul 10, 7:01AM CDT
YANTAI, China, via eTeligis Inc., 07/10/2014 - - Bohai Pharmaceuticals Group, Inc.(OTCQB: BOPH), a leading manufacturer and marketer of traditional Chinese medicine (TCM), today said that, in the first six months of this year, its products increased their market penetration by an additional 3961 hospitals in China.
JDate Launches "Get Chosen" Campaign to Mark Company's First-Ever Rebrand
Marketwire - Fri Feb 14, 7:12AM CST
JDate.com, the iconic community responsible for more Jewish marriages than all other dating sites combined, today announced the launch of a new marketing campaign that further emphasizes the "J" in JDate. The rebranding initiative, titled "Get Chosen," will resonate with the Jewish community by highlighting the cultural traditions and experiences that members of the "Chosen people" can identify with and appreciate. The creative for the campaign was conceptualized by ad agency The Terri & Sandy Solution.
LOV: 4.38 (unch)